# Exploiting full Resolution Feature Context for Liver Tumor and Vessel Segmentation via Integrate Framework: Application to Liver Tumor and Vessel 3D Reconstruction under embedded microprocessor

arXiv: https://arxiv.org/abs/2111.13299 · HTML: https://mlsanity.com/paper/2111.13299/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 15 of its 41 references that are in the map.
- First posted on arXiv 26 Nov 2021.

## Builds on (most cited first, 15 of 15)

- [Attention Is All You Need](https://mlsanity.com/paper/1706.03762/) (2017)
- [An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale](https://mlsanity.com/paper/2010.11929/) (2020)
- [U-Net: Convolutional Networks for Biomedical Image Segmentation](https://mlsanity.com/paper/1505.04597/) (2015)
- [Fully Convolutional Networks for Semantic Segmentation](https://mlsanity.com/paper/1411.4038/) (2014)
- [Squeeze-and-Excitation Networks](https://mlsanity.com/paper/1709.01507/) (2017)
- [Training data-efficient image transformers & distillation through attention](https://mlsanity.com/paper/2012.12877/) (2020)
- [Identity Mappings in Deep Residual Networks](https://mlsanity.com/paper/1603.05027/) (2016)
- [TransUNet: Transformers Make Strong Encoders for Medical Image Segmentation](https://mlsanity.com/paper/2102.04306/) (2021)
- [UNet++: A Nested U-Net Architecture for Medical Image Segmentation](https://mlsanity.com/paper/1807.10165/) (2018)
- [SegNet: A Deep Convolutional Encoder-Decoder Architecture for Image Segmentation](https://mlsanity.com/paper/1511.00561/) (2015)
- [Language Modeling with Gated Convolutional Networks](https://mlsanity.com/paper/1612.08083/) (2016)
- [Free-Form Image Inpainting with Gated Convolution](https://mlsanity.com/paper/1806.03589/) (2018)
- [UNet 3+: A Full-Scale Connected UNet for Medical Image Segmentation](https://mlsanity.com/paper/2004.08790/) (2020)
- [Gated-SCNN: Gated Shape CNNs for Semantic Segmentation](https://mlsanity.com/paper/1907.05740/) (2019)
- [DoubleU-Net: A Deep Convolutional Neural Network for Medical Image Segmentation](https://mlsanity.com/paper/2006.04868/) (2020)

## Built on by (most cited first, 1 of 1)

- [DyGLNet: Hybrid Global-Local Feature Fusion with Dynamic Upsampling for Medical Image Segmentation](https://mlsanity.com/paper/2509.12763/) (2025)

## Abstract (arXiv)

Liver cancer is one of the most common malignant diseases in the world. Segmentation and labeling of liver tumors and blood vessels in CT images can provide convenience for doctors in liver tumor diagnosis and surgical intervention. In the past decades, many state-of-the-art medical image segmentation algorithms appeared during this period. With the development of embedded devices, embedded deployment for medical segmentation and automatic reconstruction brings prospects for future automated surgical tasks. Yet, most of the existing segmentation methods mostly care about the spatial feature context and have a perception defect in the semantic relevance of medical images, which significantly affects the segmentation accuracy of liver tumors and blood vessels. Deploying large and complex models into embedded devices requires a reasonable trade-off between model accuracy, reasoning speed and model capacity. Given these problems, we introduce a multi-scale feature fusion network called TransFusionNet based on Transformer. This network achieved very competitive performance for liver vessel and liver tumor segmentation tasks, meanwhile it can improve the recognition of morphologic margins of liver tumors by exploiting the global information of CT images. Experiments show that in vessel segmentation task TransFusionNet achieved mean Dice coefficients of 0.899 and in liver tumor segmentation task TransFusionNet achieved mean Dice coefficients of 0.961. Compared with the state-of-the-art framework, our model achieves the best segmentation result. In addition, we deployed the model into an embedded micro-structure and constructed an integrated model for liver tumor vascular segmentation and reconstruction. This proprietary structure will be the exclusive component of the future medical field.